Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2026-01-06 @ 3:29 PM
Study NCT ID:
NCT01441960
Status:
COMPLETED
Last Update Posted:
2015-06-02
First Post:
2011-09-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Optimal Dose of Succinylcholine and Rocuronium for Electroconvulsive Therapy (ECT)
Sponsor:
Massachusetts General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-05
Start Date Type:
None
Primary Completion Date:
2013-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-02
Completion Date Type:
ACTUAL
First Submit Date:
2011-09-20
First Submit QC Date:
None
Study First Post Date:
2011-09-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-04-09
Results First Submit QC Date:
None
Results First Post Date:
2015-06-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-06-01
Last Update Post Date:
2015-06-02
Last Update Post Date Type:
ESTIMATED